Table 1. Patients' demographic data along with Diagnosis, Medication, Andreasen's scales for negative and positive symptom assessment.
| SANS | SAPS | ||||||||||||
| Patient | Age | Sex | Type | Medication | F. AFF. | AL. | AP. | AN. | ATT. I. | HALL. | DEL. | BIZ./D. B. | P. F. T. D. |
| F.G. | 51 | M | Disorgan. | Perphenazine enantate 8 mg/d | 6 | 0 | 6 | 10 | 6 | 10 | 4 | 11 | 22 |
| Chlorpromazine 50 mg/d | |||||||||||||
| D.D. | 41 | F | Undiffer. | Perphenazine enantate 6 mg/d | 5 | 7 | 12 | 20 | 13 | 0 | 0 | 0 | 31 |
| L.S. | 39 | M | Residual | Haloperidol 3 mg/d | 29 | 13 | 10 | 23 | 10 | 8 | 11 | 3 | 4 |
| C.A. | 49 | M | Disorgan. | Perphenazine enantate 4 mg/d | 12 | 0 | 6 | 20 | 7 | 0 | 15 | 17 | 11 |
| B.N. | 27 | F | Residual | Haloperidol 2 mg/d | 26 | 20 | 18 | 25 | 13 | 12 | 20 | 12 | 13 |
| B.I. | 60 | F | Undiffer. | Haloperidol decanoate 2 mg/d | 7 | 0 | 7 | 23 | 6 | 9 | 13 | 11 | 27 |
| Z.T. | 23 | F | Residual | Clotiapine 20 mg/d | 30 | 20 | 15 | 24 | 12 | 0 | 13 | 0 | 0 |
| P.G. | 31 | M | Residual | Clotiapine 10 mg/d | 26 | 20 | 15 | 25 | 9 | 12 | 25 | 0 | 0 |
| C.M. | 24 | M | Paranoid | Fluphenazine decanoate 2.5 mg/d | 6 | 5 | 8 | 21 | 9 | 14 | 20 | 13 | 29 |
| P.L. | 36 | F | Disorgan. | Perphenazine enantate 2 mg/d | 26 | 10 | 9 | 23 | 9 | 0 | 13 | 5 | 0 |
| P.R. | 33 | F | Residual | Levomeprazine maleate 25 mg/d | 16 | 11 | 17 | 10 | 6 | 0 | 13 | 17 | 15 |
| V.T. | 41 | M | Paranoid | Haloperidol 1 mg/d | 36 | 15 | 20 | 25 | 9 | 0 | 17 | 0 | 13 |
| Mean | 18.75 | 10.08 | 11.92 | 20.75 | 9.08 | 5.42 | 14.83 | 7.42 | 11.47 | ||||
TYPE: Disorgan. = Disorganized; Undiffer. = Undifferentiated. SANS: F.AFF. = Flattened Affect; AL. = Alogia; AP. = Apathy; AN. = Anhedonia; ATT. I. = Attentional Impairment. SAPS: HALL. = Hallucinations; DEL. = Delusions; BIZ./D. B. = Bizzarre or Disorganized Behavior; P.F.T.D. = Positive Formal Thought Disorder.